, Tracking Stock Market Picks
Enter Symbol:
Rating: FLML
Buy $21
up 44.00 %

Flamel Technologies S.a. (NASDAQ: FLML) reiterated to Buy with price target $21 by Roth Capital

Thursday,  Mar 19, 2015  3:25 PM ET by Lynn Gilbert

Roth Capital reiterated Flamel Technologies S.a. (NASDAQ: FLML) to Buy with price target $21. Previously, Roth Capital rated Flamel Technologies S.a. (NASDAQ: FLML) to Buy with
price target $17 on 01/15/2015, when the stock price was valued at $11.88. Since then, Flamel Technologies S.a.'s stock price has gained 44% as of 03/19/2015's recent price of $17.10.
If you had followed Roth Capital's previous recommendation on FLML, you would have gained 44% of your investment in 63 days.

Flamel Technologies S.A. is principally engaged in the development of advanced polymer technologies for unique medicinal applications. To meet important medical needs and develop commercially valuable products, they are building on their primary technology platforms: the Medusa system for the controlled peritoneal delivery of proteins and peptides, and the Micropump system for the controlled delivery of certain oral drugs. (press release)

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy